March 21, 2025
TOPLINE: A novel T-cell immunotherapy demonstrates superior outcomes than conventional transplant, with 78% vs 38% survival free of moderate to severe chronic graft vs host disease […]
March 21, 2025
Results from the PHENIX-I trial support skipping pelvic lymphadenectomy in women with early cervical cancer who have a negative sentinel lymph node biopsy. Omitting pelvic lymphadenectomy […]
March 21, 2025
TOPLINE: Cancer Antigen 125 (CA-125) testing shows 23% lower odds of elevated levels in American Indian and Black patients with ovarian cancer compared with White patients. […]
March 20, 2025
New findings on radiation plus adjuvant chemotherapy in patients with intermediate-risk cervical cancer seem to spell the end for the dual therapy in this group. Results […]
March 20, 2025
TOPLINE: Adjuvant therapy with camrelizumab significantly improved 3-year event-free survival in patients with locoregionally advanced nasopharyngeal carcinoma compared with observation, according to findings from the phase […]
March 20, 2025
TOPLINE: B-cell maturation antigen–directed chimeric antigen receptor (CAR) T-cell therapy demonstrated safety in patients with multiple myeloma (MM) and central nervous system (CNS) involvement, achieving an […]
March 19, 2025
The US multi-society task force on colorectal cancer (CRC) has updated its 2014 guidance for optimizing the adequacy of bowel preparation for colonoscopy. The latest consensus […]
March 18, 2025
TOPLINE: Analysis of 1,289,366 adults with cancer revealed that states with no additional short-term, limited-duration (STLD) insurance regulations saw a 0.76 percentage point increase in late-stage […]
March 18, 2025
New results from the phase 3 ENGOT-cx11/GOG-3047/KEYNOTE-A18 study showed that a combination of pembrolizumab and concurrent chemoradiotherapy (CCRT) continues to improve progression-free survival (PFS) in locally […]